Early Phase 3 Results Show Survival Benefit with Nivolumab-Based Regimens in Advanced Esophageal Squamous-Cell Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 28
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2021 AND VI 11 AND IP 11
Results: 16
1
2
FDA NEWS.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 44
- Publication type:
- Article
3
Multicancer Detection: The Need for Clinical Guidance.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 40
- By:
- Publication type:
- Article
4
Partisan Science in America.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 42
- By:
- Publication type:
- Article
5
Strategies for Helping Patients Reduce Their Financial Burden During Cancer Care.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 38
- By:
- Publication type:
- Article
6
Beyond the Bot: Virtual Assistant Success in Patient Engagement and Boosting Post-Pandemic Revenue.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 34
- Publication type:
- Article
7
ALK-Targeted Therapy May Be Benefcial in Adult-Onset Neuroblastoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 33
- By:
- Publication type:
- Article
8
Navigating Compassionate Use Options for Your Patients with Cholangiocarcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 30
- By:
- Publication type:
- Article
9
Clinical NCCN Risk Classifcation Suboptimal for Some African-American Men with Prostate Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 26
- By:
- Publication type:
- Article
10
Increasing Clinical Trial Participation in the Community Setting.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 16
- By:
- Publication type:
- Article
11
Amivantamab plus Lazertinib Combination Shows Promise in Osimertinib-Resistant EGFR-Positive NSCLC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 14
- By:
- Publication type:
- Article
12
Stakeholders Advocate for Zero Copay Policy to Lower Biosimilars Costs for Medicare Part B Patients.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 13
- Publication type:
- Article
13
Analysis of Healthcare Claims Shows Encouraging Trend in the Use of Trastuzumab Biosimilars.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 12
- By:
- Publication type:
- Article
14
Survey Reveals Ongoing Misconceptions and Concerns Regarding Biosimilars.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 1
- By:
- Publication type:
- Article
15
The Benefits of Advance Care Planning During the COVID-19 Pandemic.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 1
- By:
- Publication type:
- Article
16
New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 1
- By:
- Publication type:
- Article